Two Sigma Investments’s Immune Design Corp. IMDZ Stock Holding History

Two Sigma Investments’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-196,624	Closed	-$1.15M	–	3885
2019 Q1	$1.15M	Sell	196,624 -218,630	-53%	-$745K	﹤0.01%	1732
2018 Q4	$540K	Buy	415,254 +274,335	+195%	+$477K	﹤0.01%	2052
2018 Q3	$486K	Buy	140,919 +48,805	+53%	+$183K	﹤0.01%	2470
2018 Q2	$419K	Sell	92,114 -38,896	-30%	-$155K	﹤0.01%	2747
2018 Q1	$432K	Sell	131,010 -86,907	-40%	-$308K	﹤0.01%	2559
2017 Q4	$850K	Buy	217,917 +201,441	+1,223%	+$1.1M	﹤0.01%	2070
2017 Q3	$171K	Buy	+16,476	New	+$162K	﹤0.01%	2613

Two Sigma Investments's IMDZ Position: Q2 2019 in Review

Two Sigma Investments sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 196,624 shares — an estimated $1.15M sold.

Two Sigma Investments first reported a position in IMDZ in Q3 2017 and held it in 7 quarters. The position peaked at $1.15M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Two Sigma Investments reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Two Sigma Investments sold 196,624 Immune Design Corp. shares in Q2 2019, an estimated $1.15M.
Two Sigma Investments first reported a position in Immune Design Corp. in Q3 2017 and held it in 7 quarters.
Two Sigma Investments's Immune Design Corp. position peaked at $1.15M in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Two Sigma Investments's 13F filing for Q2 2019, filed 14 Aug 2019.